CLIMB BIO INC (CLYM)
US28658R1068 - Common Stock
CLIMB BIO INC
NASDAQ:CLYM (12/23/2024, 8:00:00 PM)
After market: 1.92 0 (0%)1.92
-0.03 (-1.54%)
Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
CRS0
6 MonthN/A
Overview
Earnings (Last)
Earnings (Next)
Ins OwnersN/A
Inst OwnersN/A
Market Cap0
SharesN/A
PEN/A
Fwd PEN/A
Dividend YieldN/A
AnalystsN/A
Short Float %N/A
Short Ratio17.7
IPO
CLYM News
5 days ago - Climb Bio, Inc.Climb Bio to be Added to the Nasdaq Biotechnology Index5 days ago - Climb Bio, Inc.Climb Bio to be Added to the Nasdaq Biotechnology IndexWELLESLEY HILLS, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- December 19, 2024 – Climb Bio, Inc. (Nasdaq: CLYM) today announced that the company will be...
a month ago - Climb Bio, Inc.Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlightsa month ago - Climb Bio, Inc.Climb Bio Reports Third Quarter 2024 Financial Results and Business HighlightsAppointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus...
a month ago - Climb Bio, Inc.Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Boarda month ago - Climb Bio, Inc.Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the BoardWELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as...
CLYM Twits
Here you can normally see the latest stock twits on CLYM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
